Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

European Journal of Cancer

Volumn 35, Issue 7, 1999, Pages 1089-1093

  Lee, Y H ^a   Tokunaga, T ^a   Oshika, Y ^a   Suto, R ^a   Yanagisawa, K ^a   Tomisawa, M ^a   Fukuda, H ^a   Nakano, H ^b   Abe, S ^b   Tateishi, A ^b   Kijima, H ^a   Yamazaki, H ^a   Tamaoki, N ^a   Ueyama, Y ^a   Nakamura, M ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Isoform pattern; Osteosarcoma; Vascular endothelial growth factor (VEGF)

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BONE BIOPSY; CARCINOGENESIS; CELL SURFACE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; NEOVASCULARIZATION (PATHOLOGY); OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENCE ANALYSIS; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BONE NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PROGNOSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033166894     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00073-8     Document Type: Article

References (31)

1. Rosen G., Suwansirikul S., Kwon C., Wu S.J., Beattie E.J. Jr., Murphy M.L. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer. 33:1974;1151-1163.
2. Coomber B.L., Denton J., Sylvestre A., Kruth S. Blood vessel density in canine osteosarcoma. Can. J. Vet. Res. 62:1998;199-204.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
4. Keck P.J., Hauser S.D., Krivi G.et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
5. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
6. Ferrara N., Carver-Moore K., Chen H.et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
7. Lee A.H., Dublin E.A., Bobrow L.G., Poulsom R. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J. Pathol. 185:1998;394-401.
8. Mattern J., Koomagi R., Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer. 73:1996;931-934.
9. Berse B., Brown L.F., Vav De Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumours. Mol. Biol. Cell. 3:1992;211-220.
10. Boocock C.A., Charnock-Jones D.S., Sharkey A.M.et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer Inst. 87:1995;506-516.
11. Suzuki K., Hayashi N., Miyamoto Y.et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 56:1996;3004-3009.
12. Tokunaga T., Oshika Y., Abe Y.et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer. 77:1998;998-1002.
13. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family. identification of a fourth molecular species and characterization of alternative splicing of RNA Mol. Endocrinol. 5:1991;1806-1814.
14. Poltorak Z., Cohen T., Sivan R.et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem. 272:1997;7151-7158.
15. Cheung C.Y., Singh M., Ebaugh M.J., Brace R.A. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am. J. Obstet. Gynecol. 173:1995;753-759.
16. Park J., Keller G-A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms. differential disposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol. Biol. Cell. 4:1993;1317-1326.
17. Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:1992;26031-26037.
18. Cohen T., Gitay-Goren H., Sharon R.et al. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparin sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 170:1995;11322-11326.
19. Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:1992;26031-26037.
20. Tokunaga T., Nakamura M., Oshika Y., Ohnishi Y., Ueyama Y. Is xenotransplantability of human colon cancers in SCID mice affected by angiogenic factors? J. Natl. Cancer Inst. 90:1998;400-401.
21. Oshika Y., Nakamura M., Tokunaga T.et al. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int. J. Oncol. 12:1998;541-544.
22. Tomisawa M., Tokunaga T., Oshika Y.et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur. J. Cancer. 35:1999;133-137.
23. Tokunaga T., Nakamura M., Oshika Y.et al. Thrombospondin-2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br. J. Cancer. 79:1999;354-359.
24. Bochner B.H., Cote R.H., Weidner N.et al. Angiogenesis in bladder cancer. relationship between microvessel density and tumor prognosis J. Natl. Cancer Inst. 87:1995;1603-1612.
25. Sobin LH, Wittekind C. International Union Against Cancer, TNM Classification of Malignant Tumours (5th edition). New York, Wiley-Liss Inc., 1997, 103-105.
26. Asai T., Ueda T., Itoh K.et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int. J. Cancer. 76:1998;418-422.
27. 3 in human osteoblast-like cells. J Bone and Mineral Res. 11:1996;472-479.
28. Ellis L.M., Walker R.A., Gasparini G. Is determination of angiogenic activity in human tumours clinically useful? Eur. J. Cancer. 34:1998;609-618.
29. Weidner N., Carro P.R., Flax J., Blumenfeld W., Folkman J. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:1995;9-19.
30. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
31. Midy V., Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199:1994;380-386.